Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

3,5-diiodothyropropionic acid

Known as: 3,5-DITPA, Benzenepropanoic acid, 4-(4-hydroxyphenoxy)-3,5-diiodo-, DITPA cpd 
 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

DiiodothyroninesPropionates

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Thyroid hormone analog 3,5-diiodothyropropionic acid promotes healthy vasculature in the adult myocardium independent of thyroid effects on cardiac function.
Patients with hypothyroidism are at a higher risk for coronary vascular disease. Patients with diabetes and related vascular… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2008
Review
2008
Metabolic effects of thyroid hormone derivatives.
The processes and pathways mediating the intermediary metabolism of carbohydrates, lipids, and proteins are all affected by… Expand
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Proangiogenesis action of the thyroid hormone analog 3,5-diiodothyropropionic acid (DITPA) is initiated at the cell surface and is integrin mediated.
We have recently described the proangiogenesis effects of thyroid hormone in the chick chorioallantoic membrane (CAM) model… Expand
Is this relevant?
Review
2004
Review
2004
Effects of thyroid hormone on the cardiovascular system.
Increased or reduced action of thyroid hormone on certain molecular pathways in the heart and vasculature causes relevant… Expand
  • table I
  • figure 1
Is this relevant?
Highly Cited
2003
Highly Cited
2003
DITPA stimulates bFGF, VEGF, angiopoietin, and Tie-2 and facilitates coronary arteriolar growth.
Previous studies from our laboratory and those of others have shown thyroxine to be a stimulator of coronary microvascular growth… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Review
2002
Review
2002
Clinical and experimental studies on the use of 3,5-diiodothyropropionic acid, a thyroid hormone analogue, in heart failure.
Thyroid hormone has unique actions that make it a novel and possibly useful agent for treatment of heart failure. Because of… Expand
Is this relevant?
2002
2002
Pilot Studies on the Use of 3,5-Diiodothyropropionic Acid, a Thyroid Hormone Analog, in the Treatment of Congestive Heart Failure
After an initial safety study in 7 normal volunteers, a randomized double-blind comparison was made between 3,5… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2000
2000
Prevention of abnormal sarcoplasmic reticulum calcium transport and protein expression in post-infarction heart failure using 3, 5-diiodothyropropionic acid (DITPA).
Heart failure of diverse causes is associated with abnormalities of sarcoplasmic reticulum (SR) Ca(2+)transport. The purpose of… Expand
Is this relevant?
1993
1993
Combination treatment with captopril and the thyroid hormone analogue 3,5-diiodothyropropionic acid. A new approach to improving left ventricular performance in heart failure.
BACKGROUND An agent that improves left ventricular (LV) performance by non-cAMP-mediated mechanisms would be valuable in the… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
1992
Highly Cited
1992
Cardiac effects of 3,5-diiodothyropropionic acid, a thyroid hormone analog with inotropic selectivity.
Thyroid hormone exerts a strong positive inotropic action on the heart and induces alpha-myosin heavy chain (MHC) gene expression… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE